38 results on '"Zueger, Patrick"'
Search Results
2. A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis
3. One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib
4. Wearable activity tracker study exploring rheumatoid arthritis patients’ disease activity using patient-reported outcome measures, clinical measures, and biometric sensor data (the wear study)
5. Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry
6. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials
7. Correction: Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry
8. Experiences and Treatment Preferences in Patients With Psoriatic Arthritis: A Cross-Sectional Study in the ArthritisPower Registry
9. Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2
10. Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
11. Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
12. Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
13. Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States.
14. Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission
15. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study
16. Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective
17. Use of Nonpalliative Medications Following Burdensome Health Care Transitions in Hospice Patients: A Matched Cohort Analysis
18. Wearable Activity Tracker Study Exploring Rheumatoid Arthritis Patients’ Disease Activity Using Patient-Reported Outcome Measures, Clinical Measures, and Biometric Sensor Data (the Wear Study)
19. Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry
20. Assessing Outcomes and Perceived Benefits of a Professional Development Seminar Series
21. Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials
22. Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review
23. Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study
24. Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
25. P173 Efficacy and safety of upadacitinib versus placebo and adalimumab in patients with active PsA and inadequate response to non-biologic DMARDs (SELECT-PSA-1): a double-blind, randomised controlled phase III trial
26. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
27. P171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial
28. Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
29. Site-Specific Resolution of Enthesitis in Patients With Axial Spondyloarthritis Treated With Tumor Necrosis Factor Inhibitors
30. Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry
31. FRI0438 TREATMENT UTILISATION PATTERNS OF ADVANCED THERAPIES IN PSORIATIC ARTHRITIS
32. FRI0375 SITE-SPECIFIC EFFECTIVENESS OF TNF INHIBITORS FOR ENTHESITIS IN DMARD-NAIVE PATIENTS WITH AXIAL SPONDYLOARTHRITIS
33. Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2.
34. Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry.
35. Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United States
36. Medicare Part D Use of Older Medicare Beneficiaries Admitted to Hospice
37. Satisfaction With Medication Therapy Management Services at a University Ambulatory Care Clinic
38. Satisfaction With Medication Therapy Management Services at a University Ambulatory Care Clinic.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.